Opinion and Comment

データ共有の設計から始めよ

Nature Biotechnology 34, 4 doi: 10.1038/nbt.3516

To upend current barriers to sharing clinical data and insights, we need a framework that not only accounts for choices made by trial participants but also qualifies researchers wishing to access and analyze the data.

目次へ戻る

プライバシーマーク制度